Monday, June 1, 2026
HomeHeadlineCanada Recalls Omnipod Insulin Pump Supplies; Diabetes Patients and Families Should Check...

Canada Recalls Omnipod Insulin Pump Supplies; Diabetes Patients and Families Should Check Lot Numbers

TORONTO, June 1, 2026 – Health Canada issued a medical device recall notice on May 29 involving certain lots of Omnipod insulin management system products. According to the official notice, the exposed soft cannula in some products may tear, affecting insulin delivery. If insulin delivery is reduced or interrupted, users may experience high blood sugar, and in severe cases, this could develop into diabetic ketoacidosis requiring timely medical care. For diabetes patients using Omnipod, families caring for children or seniors with diabetes, and newcomer patients with limited English, the most important step now is to check the lot numbers of supplies at home, rather than judging only by the brand name.

The affected products listed on Health Canada’s recall page include certain products and lot numbers under the Omnipod Insulin Management System, Omnipod 5 Automated Insulin Delivery System and Omnipod DASH. Official information shows the issue is related to tearing of the exposed soft cannula, which may disrupt the infusion path and reduce or interrupt insulin delivery. Manufacturer Insulet also said in its user notice that some Pods may have small cracks in the soft cannula, meaning insulin may not enter the body as intended. Some users may notice moisture on the skin or adhesive patch, or smell insulin, but the issue may also be difficult to detect.

This type of recall can easily be misunderstood by patient families. Many people keep multiple boxes of supplies at home and may not know whether their own products are affected after seeing “Omnipod recall.” Others may only look at the brand name on the front of the box and fail to check the lot number and model. For families caring for children or seniors with diabetes, if family members cannot read English instructions or supplies were delivered in different batches from pharmacies or suppliers, each box should be checked carefully.

According to official instructions, users should check the lot number on the Pod tray lid, the side of the 10-pack box, or the flat side of the Pod itself, and compare it with the affected lot number list. Insulet said all Pods in the same box are usually from the same lot. If that lot is affected, all unused Pods in the box should not continue to be used. Users can also follow the instructions in the manufacturer’s notification email to confirm the lot number and request replacements.

If a Pod currently in use comes from an affected lot, the official advice is to replace it immediately with an unaffected Pod to restore insulin delivery. If the recall leaves a patient without enough usable supplies, they should contact their health-care provider to confirm an alternative insulin delivery method while waiting for replacements. Patients should not stop treatment on their own without an alternative plan, nor should they rely only on device alarms to judge safety, as the manufacturer said this issue may occur without an alarm.

It is important to note that the recall does not mean all Omnipod products are affected. Insulet said Pods that are not included in the affected lot numbers can still be used, and Health Canada’s recall page lists the specific affected products, lot numbers and models. Patients who are unsure whether their products are affected can contact Insulet product support, their pharmacy, diabetes education team, family doctor or specialist team for help checking. The Canadian support number listed by the manufacturer is 1-855-763-4636, and Insulet says it is available 24 hours a day.

For families of diabetes patients, especially those caring for children, seniors or patients facing language barriers, Omnipod supplies at home should be checked together in the near future. Families should record lot numbers, models, purchase or delivery sources, and keep notices from pharmacies, suppliers and the manufacturer. If blood sugar rises significantly, insulin delivery appears abnormal, the adhesive area becomes wet, or other unusual signs appear, patients should follow their personal medical plan as soon as possible and contact a medical professional to confirm next steps.

This is not an ordinary consumer product recall, but a medical device recall related to the continuity of daily treatment. Patients or caregivers who cannot understand English instructions should ask family members, pharmacists or medical teams to help check lot numbers and replacement procedures, so they do not mistakenly use affected supplies or stop necessary treatment out of concern over the recall.(LJI by Yuanyuan)

- Advertisment -

Must Read